Skip to main content

GLYCOMIMETICS INC

For the period ended Sep 30, 2024. Filed Nov 13, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 13, 2024

CBIO$13.65+0.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

​​​
ExhibitNo.​Document
​​​
3.1​Amended and Restated Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-36177), filed with the Commission on January 15, 2014).
​​​
3.2​Amended and Restated Bylaws of the Registrant (incorporated herein by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K (File No. 001-36177), filed with the Commission on January 15, 2014).
​​​
3.3​Certificate of Amendment to the Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-36177), filed with the Commission on May 1, 2024).
​​​
3.4​Certificate of Amendment to the Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K (File No. 001-36177), filed with the Commission on May 1, 2024).
​​​
4.1​Specimen stock certificate evidencing shares of Common Stock (incorporated herein by reference to Exhibit 4.2 to Amendment No. 2 to the Registrant’s Registration Statement on Form S-1 (File No. 333-191567), filed with the Commission on October 31, 2013).
​​​
10.1*+​Retention Agreement, dated as of August 7, 2024, by and between the Registrant and Harout Semerjian.
​​​
10.2*+​Retention Agreement, dated as of August 7, 2024, by and between the Registrant and Brian Hahn.
​​​
10.3*+​Separation Agreement, dated as of July 30, 2024, by and between the Registrant and Edwin Rock.
​​​
10.4*+​Consulting Agreement, dated as of July 31, 2024, by and between the Registrant and Edwin Rock.
​​​
31.1*​Certification of Principal Executive Officer under Section 302 of the Sarbanes-Oxley Act.
​​​
31.2*​Certification of Principal Financial Officer under Section 302 of the Sarbanes-Oxley Act.
​​​
32.1**​Certifications of Principal Executive Officer and Principal Financial Officer under Section 906 of the Sarbanes-Oxley Act.
​​​
101.INS*​Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document)
​​​
101.SCH*​Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents
​​​
104*​Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*Filed herewith.

** These certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

+Indicates management contract or compensatory plan.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.